Evidence map›Paper›PMID 23955570›Full record

ArticleCellular and molecular life sciences : CMLS2014

Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation.

Konstantin Knoblich, Hong-Xing Wang, Chandan Sharma, Anne L Fletcher, Shannon J Turley, Martin E Hemler

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Significance of Malic Enzyme 1 in Cancer: A Review.Current issues in molecular biology · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. MicroRNA-495: a therapeutic and diagnostic tumor marker.Journal of molecular histology · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Konstantin KnoblichCancer Immunology and AIDS, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
Hong-Xing Wang
Chandan Sharma
Anne L Fletcher
Shannon J Turley
Martin E Hemler
Dana-Farber Cancer Institute · USMonash University · AU

Funding

Support of carcinoma metastasis by integrin a6-CD151-PKC complexesR01CA042368 · NCI · DANA-FARBER CANCER INSTITUTE · PI HEMLER, MARTIN E · 1986 to 2019
$5.4M
NCI NIH HHS CA42368NCI NIH HHS R01 CA042368
6 · The paper itself

Abstract

Ablation of tetraspanin protein TSPAN12 from human MDA-MB-231 cells significantly decreased primary tumor xenograft growth, while increasing tumor apoptosis. Furthermore, TSPAN12 removal markedly enhanced tumor-endothelial interactions and increased metastasis to mouse lungs. TSPAN12 removal from human MDA-MB-231 cells also caused diminished association between FZD4 (a key canonical Wnt pathway receptor) and its co-receptor LRP5. The result likely explains substantially enhanced proteosomal degradation of β-catenin, a key effecter of canonical Wnt signaling. Consistent with disrupted canonical Wnt signaling, TSPAN12 ablation altered expression of LRP5, Naked 1 and 2, DVL2, DVL3, Axin 1, and GSKβ3 proteins. TSPAN12 ablation also altered expression of several genes regulated by β-catenin (e.g. CCNA1, CCNE2, WISP1, ID4, SFN, ME1) that may help to explain altered tumor growth and metastasis. In conclusion, these results provide the first evidence for TSPAN12 playing a role in supporting primary tumor growth and suppressing metastasis. TSPAN12 appears to function by stabilizing FZD4-LRP5 association, in support of canonical Wnt-pathway signaling, leading to enhanced β-catenin expression and function.

Indexed as

AnimalsApoptosisbeta CateninBreast NeoplasmsFemaleFrizzled ReceptorsGene Expression RegulationGene SilencingHumansHuman Umbilical Vein Endothelial CellsLow Density Lipoprotein Receptor-Related Protein-5MiceMice, SCIDNeoplasm MetastasisTetraspaninsWnt Proteinsbeta CateninFrizzled ReceptorsFZD4 protein, humanLow Density Lipoprotein Receptor-Related Protein-5LRP5 protein, humanTetraspaninsTSPAN12 protein, humanWnt Proteins

Identifiers

PMID23955570
PMCPMC11113286
OpenAlexW2015700573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.